Effect of a Low FODMAP Diet on SIBO
Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Nov 12, 2020
Trial Information
Current as of April 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-65 years at the time of screening
- • Meet Rome IV criteria for functional bloating
- • IBS-SSS score of at 176 (0-500)
- • SIBO positive
- Exclusion Criteria:
- • individuals already on a LFD or other dietary restriction such as gluten free diet within the past 6 months
- • individuals with peanut, soy, or seafood allergies or insulin-dependent diabetes
- • known history of celiac disease, inflammatory bowel disease or microscopic colitis
- • prior small bowel or colonic surgery or cholecystectomy
- • pregnant patients
- • antibiotics, excluding topical, in the past 3 months
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center (BIDMC) is a leading academic medical center located in Boston, Massachusetts, affiliated with Harvard Medical School. Renowned for its commitment to cutting-edge research and innovation in healthcare, BIDMC fosters a collaborative environment that integrates patient care, education, and scientific investigation. The center actively sponsors clinical trials across a variety of disciplines, aiming to advance medical knowledge and improve patient outcomes. With a focus on translational medicine, BIDMC's research initiatives engage multidisciplinary teams to address complex health challenges and translate findings into effective therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials